Publications by authors named "Bassam Mattar"

Claim this Profile
O
OUTREACH: phase 2 study of lisocabtagene maraleucel as outpatient or inpatient treatment at community sites for R/R LBCL.
Yuliya Linhares, Cesar O Freytes, Mohamad Cherry, Carlos Bachier, Michael Maris, Bassam Mattar

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World Experience.
Khalil Choucair, Seth J Page, Bassam I Mattar, Christopher S Dakhil, Nassim H Nabbout

Clin Breast Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice.
Khalil Choucair, Bassam Ibrahim Mattar, Quoc Van Truong, Travis Koeneke, Phu Van Truong

Oncologist· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Alex F Herrera, Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Bassam Mattar

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).
Harry H Yoon, Fang-Shu Ou, Gamini S Soori, Qian Shi, Dennis A Wigle, Bassam Ibrahim Mattar

Eur J Cancer· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Lynne I Wagner, Fengmin Zhao, Paul E Goss, Judith-Anne W Chapman, Lois E Shepherd, Bassam I Mattar

Breast Cancer Res Treat· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance).
Debra L Barton, Lynne T Shuster, Travis Dockter, Pamela J Atherton, Jacqueline Thielen, Bassam Mattar

Support Care Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
Eric M Cheung, William J Edenfield, Bassam Mattar, Stephen P Anthony, Peter J Mutch

J Clin Pharmacol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Prospective Randomized Comparison Trial of Depot Octreotide Plus Interferon Alfa-2b Versus Depot Octreotide Plus Bevacizumab in Patients With Advanced Carcinoid Tumors: SWOG S0518.
James C Yao, Katherine A Guthrie, Cesar Moran, Jonathan R Strosberg, Matthew H Kulke, Bassam Mattar

J Clin Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.
David P Steensma, Shaker R Dakhil, Paul J Novotny, Jeff A Sloan, David B Johnson, Bassam I Mattar

Am J Hematol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.
Yujie Zhao, Nathan R Foster, Jeffrey P Meyers, Sachdev P Thomas, Donald W Northfelt, Bassam I Mattar

J Thorac Oncol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338.
Vivek Roy, Barbara A Pockaj, Jacob B Allred, Heidi Apsey, Donald W Northfelt, Bassam Mattar

Am J Clin Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac angiosarcoma presenting with tamponade.
Elie Chalhoub, Bassam I Mattar, Wassim Shaheen, Thomas K Schulz

Intern Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.
Sherry L Wolf, Debra L Barton, Rui Qin, Edward J Wos, Jeff A Sloan, Bassam I Mattar

Support Care Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
Debra L Barton, Edward J Wos, Rui Qin, Bassam I Mattar, Nathan Benjamin Green

Support Care Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5).
Debra L Barton, Pamela J Atherton, Brent A Bauer, Dennis F Moore, Bassam I Mattar

J Support Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1).
Lisa A Kottschade, Vera J Suman, Thomas Amatruda, Robert R McWilliams, Bassam I Mattar

Cancer· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4).
Aminah Jatoi, Abby Thrower, Jeff A Sloan, Patrick J Flynn, Nicole Lea Wentworth-Hartung, Bassam I Mattar

Oncologist· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of oral topotecan and intravenous carboplatin with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: A North Central Cancer Treatment Group Study.
Alan H Bryce, Bassam Mattar, Shauna L Hillman, Alex A Adjei, John W Kugler

Am J Clin Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).
Aminah Jatoi, Howard L Ritter, Amylou Dueck, Phuong L Nguyen, Daniel A Nikcevich, Bassam I Mattar

Lung Cancer· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy.
Stephanie L Hines, Jeff A Sloan, Pamela J Atherton, Edith A Perez, Shaker R Dakhil, Bassam I Mattar

Breast· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.
Debra L Barton, Gamini S Soori, Brent A Bauer, Jeff A Sloan, Patricia A Johnson, Bassam Mattar

Support Care Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexplained hemopericardium as a presenting feature of primary cardiac angiosarcoma: a case report and a review of the diagnostic dilemma.
Hazem Edmond El-Osta, Youssef S Yammine, Bassem M Chehab, Andrew S Fields, Dennis F Moore, Bassam I Mattar

J Thorac Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.
Barbara Burtness, Meredith A Goldwasser, William Flood, Bassam Mattar, Arlene A Forastiere

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis